Cannula Market Share and Competitive Landscape Outlook Through 2035

Nikita Agrawal

Jun 24, 2025 - 10:16

The global Cannula Market is experiencing robust growth, valued at USD 191.7 million in 2025 and projected to reach USD 555.8 million by 2035, reflecting a compound annual growth rate (CAGR) of 11.2%. This expansion is driven by the increasing prevalence of chronic diseases, a surge in minimally invasive surgeries (MIS), and advancements in cannula design, such as antimicrobial coatings and biocompatible materials. The market is further propelled by rising healthcare expenditure, an aging global population, and growing demand for aesthetic and home healthcare procedures.

Cannulas, flexible hollow tubes used for delivering or removing fluids, medications, or gases, are critical in medical procedures like intravenous (IV) therapy, cardiac surgeries, and oxygen delivery. Their role in enhancing patient outcomes through reduced recovery times and minimal trauma has made them indispensable in hospitals, clinics, and home care settings. Innovations like high-flow nasal cannulas and smart cannulas with sensors are expanding their applications, particularly in managing cardiovascular and respiratory disorders.

For more insights, request a sample of this report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=7770

Market Analysis

The cannula market is driven by the global rise in chronic diseases, with cardiovascular conditions causing 17.9 million deaths annually and diabetes affecting 38.4 million people in the U.S. alone, necessitating frequent use of cannulas for medication delivery and fluid management. The shift toward minimally invasive procedures, which reduce surgical trauma and recovery times, has increased demand for specialized cannulas in procedures like cardiac catheterization and cosmetic surgeries. Technological advancements, such as Masimo’s softFlow nasal cannula launched in 2021, enhance patient comfort and procedural efficiency. Rising healthcare investments and government initiatives for affordable healthcare further support market growth. However, challenges include stringent regulatory frameworks, such as the U.S. FDA’s 510(k) requirements, which delay product launches and increase costs. Risks of catheter-related bloodstream infections (CRBSIs) and a shortage of skilled professionals for cannulation, particularly in developing regions, also hinder market expansion. Additionally, high costs of advanced cannulas and competition from alternative devices like full-face masks pose restraints.

Segment Analysis

The cannula market is segmented by product, application, material, and end user. By product, cardiac cannulas dominate, holding a 45% share in 2025, driven by the high prevalence of cardiovascular surgeries like coronary artery bypass grafting (CABG), with over 500,000 procedures annually in the U.S. Nasal cannulas are the fastest-growing segment, projected to grow at a 12% CAGR, fueled by demand for high-flow oxygen therapy in respiratory care. By application, cardiovascular surgery leads due to the rising incidence of heart diseases, while aesthetic procedures, such as dermal filler injections, are growing rapidly due to consumer interest in cosmetic enhancements. By material, plastic cannulas hold the largest share for their cost-effectiveness and flexibility, while silicone is gaining traction for its biocompatibility in high-flow nasal applications. By end user, hospitals account for the largest revenue share due to high surgical volumes, with over 35 million inpatient stays in U.S. hospitals in 2022, while ambulatory surgical centers (ASCs) are growing at a CAGR of 8.3%, driven by outpatient procedure trends.

Country-wise Insights

In the United States, the cannula market is a global leader, valued at USD 67.1 million in 2025, with a projected CAGR of 8.0% through 2035, reaching USD 152.9 million. The U.S. benefits from advanced healthcare infrastructure, high surgical volumes, and innovations like antimicrobial-coated cannulas, though stringent FDA regulations and infection risks challenge growth. North America holds over 35% of the global market share, driven by the U.S.’s 695,000 annual cardiovascular deaths and widespread adoption of MIS. In the United Kingdom, the market is expected to grow at a CAGR of 7.5%, reaching USD 25.8 million by 2035. The UK’s market is fueled by rising chronic disease prevalence and adoption of advanced cannulas in cosmetic and respiratory care, but GDPR compliance for smart cannulas and limited rural healthcare access pose hurdles.

Key Players

Medtronic plc

Edwards Lifesciences Corporation

Terumo Corporation

Boston Scientific Corporation

Fisher & Paykel Healthcare Limited

Braun Melsungen AG

Strategic Outlook and Industry Trends

The cannula market is evolving through technological innovation and a focus on patient safety. Advances in materials, such as silicone and antimicrobial coatings, reduce infection risks and improve comfort, as seen in Intersurgical’s i-flo nasal cannula. The rise of smart cannulas with sensors for real-time monitoring is a key trend, particularly in critical care. The growing popularity of MIS, driven by benefits like reduced scarring and faster recovery, is boosting demand for specialized cannulas in cosmetic and cardiovascular procedures. Strategic acquisitions, like B. Braun’s regional market expansions, and partnerships, such as Convatec’s collaboration with Beta Bionics in 2023, enhance product portfolios. Manufacturers are also exploring eco-friendly materials to align with sustainability goals. To sustain growth, companies must address regulatory challenges, invest in R&D for cost-effective solutions, and expand into emerging markets with rising healthcare demands.

Segmentation of Cannula Market

By Product:

Cardiac Cannulas

Nasal Cannulas

Vascular Cannulas

Dermatology Cannulas

Arthroscopy Cannulas

Others

By Application:

Cardiovascular Surgery

Oxygen Therapy

General Surgery